Diabetes (Type 1)



Impact of the Continuous Measurement of Blood Glucose on Insulin Pump on Child Quality of Life With Type 1 Diabetes


Condition:   Type1diabetes
Interventions:   Behavioral: Peds QL questionnaire and diabetes modulate;   Behavioral: WHO-5 questionnaire;   Behavioral: Felt questionnaire
Sponsor:   Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Active, not recruiting


Group Education Curriculum for Older Teens With Type 1 Diabetes


Condition:   Type 1 Diabetes Mellitus
Intervention:   Behavioral: Intervention
Sponsor:   Boston Children’s Hospital
Recruiting


Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes


Condition:   Type 1 Diabetes
Interventions:   Drug: Ergocalciferol;   Other: Placebo
Sponsor:   University of Massachusetts, Worcester
Recruiting


Use of Continuous Glucose Monitoring System With Intensive Feedback in Adolescents With Poorly Controlled Type 1 Diabetes


Condition:   Type 1 Diabetes
Interventions:   Device: CGMS Device;   Other: No Device
Sponsor:   New York University School of Medicine
Enrolling by invitation


Metabolic Profiling of Type 1 Diabetes Mellitus in Children and Adolescents


Condition:   Type1diabetes
Intervention:   Other: Blood sampling
Sponsors:   Hasselt University;   Jessa Hospital
Completed


Study the Feasibility of Permanent Use of inControl for the Treatment of Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Device: insulin pump to inControl AP platform
Sponsors:   University Hospital, Montpellier;   MEDBIOMED, Montpellier, France;   Jaeb Center for Health Research;   University of Virginia
Recruiting


A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes


Condition:   Diabetes Mellitus, Insulin-Dependent
Interventions:   Drug: Ladarixin;   Drug: Placebo
Sponsor:   Dompé Farmaceutici S.p.A
Recruiting


Gene-virus Interactions Implicated in Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Genetic: Enterovirus vaccination
Sponsor:   Hospices Civils de Lyon
Not yet recruiting


Modulation of STAT3 Signaling With Siltuximab in Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Drug: Siltuximab
Sponsors:   Carla Greembaum, MD;   Janssen Research & Development, LLC
Active, not recruiting


Young With Diabetes Type 1 - Test of an mHealth App


Condition:   Diabetes Mellitus, Type 1
Intervention:   Device: Young with Diabetes - app
Sponsors:   Nordsjaellands Hospital;   Herlev Hospital;   Steno Diabetes Center;   Zealand University Hospital
Completed


The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With Type 1 Diabetes Mellitus (T1DM)


Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Dapagliflozin 5 mg;   Drug: Dapagliflozin 10mg
Sponsor:   AstraZeneca
Completed


Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus


Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Pramlintide acetate;   Drug: Placebo;   Drug: Lispro insulin U-100;   Drug: Regular insulin U-100
Sponsors:   AstraZeneca;   Juvenile Diabetes Research Foundation
Completed


Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus


Condition:   Diabetes Mellitus, Type 1
Interventions:   Biological: Albiglutide weekly injection;   Biological: Placebo weekly injection;   Biological: Insulin
Sponsor:   GlaxoSmithKline
Active, not recruiting


Pancreas Volume in Preclinical Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Procedure: MRI, US, and blood samples
Sponsors:   University of Florida;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting


Telemedicine for Adolescents With Insulin-dependent Diabetes


Condition:   Type 1 Diabetes
Interventions:   Other: Telemedicine;   Other: Control
Sponsor:   Texas Tech University Health Sciences Center
Active, not recruiting


Clinical Trial of Efficiency and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus


Condition:   Type I Diabetes Mellitus
Interventions:   Drug: Subetta;   Drug: Placebo
Sponsor:   Materia Medica Holding
Completed


52 Week Trial of Liraglutide in Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Drug: Liraglutide
Sponsors:   CHU de Quebec-Universite Laval;   Novo Nordisk A/S
Unknown status


Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus


Condition:   Type 1 Diabetes
Intervention:   Device: DIABECELL (R)
Sponsor:   Diatranz Otsuka Limited
Completed


Islet Allotransplantation in Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Drug: Human Pancreatic Islets
Sponsor:   Ohio State University
Enrolling by invitation


Imaging of Type 1 Diabetes Progression


Condition:   Type 1 Diabetes
Intervention:   Drug: ferumoxytol
Sponsors:   Jason Gaglia;   National Institute of Allergy and Infectious Diseases (NIAID);   Harvard Medical School
Active, not recruiting


Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Other: Transition Coordinator
Sponsors:   University of Western Ontario, Canada;   Juvenile Diabetes Research Foundation
Active, not recruiting


Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2


Condition:   Diabetes Mellitus, Type 1
Interventions:   Biological: Otelixizumab;   Biological: Placebo
Sponsors:   GlaxoSmithKline;   Juvenile Diabetes Research Foundation
Completed


Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes


Condition:   Type 1 Diabetes
Interventions:   Drug: Sitagliptin;   Drug: Sugar Pill
Sponsor:   University of Colorado Denver School of Medicine Barbara Davis Center
Completed


Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus


Condition:   Type 1 Diabetes
Intervention:   Device: DIABECELL(R)
Sponsor:   Diatranz Otsuka Limited
Completed


Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes


Condition:   Type 1 Diabetes
Interventions:   Device: Closed loop;   Device: Home glucose monitoring;   Device: Insulin pump;   Device: Continuous glucose monitor
Sponsor:   Jaeb Center for Health Research
Terminated

Refine Your Search Advanced Search